2018 Oncology Annual Report

2018 ANNUAL REPORT

TableofContents Oncology Program Leadership and Staff...................................................................................................................... 3 A Comprehensive Approach to Quality Care................................................................................................................. 4 Operations Leadership Corner........................................................................................................................................... 5 2018 Highlights and Achievements................................................................................................................................ 6 Genetic Counseling Corner................................................................................................................................................ 9 Oncology Data Services. ...................................................................................................................................................10 Cancer Registry Data – 2017 Analytic Cases..............................................................................................................11 Outcomes...............................................................................................................................................................................13 Outcomes: Quality Improvement..................................................................................................................................15 Providing Exceptional Cancer Care Close to Home.................................................................................................16 Nurse Navigator’s Corner...................................................................................................................................................17 Taking Care and Giving Back...........................................................................................................................................18 AtlantiCare Cancer Committee Members...................................................................................................................19

Published December 2018

2 AtlantiCare Cancer Care Institute: Annual Report 2018

AtlantiCare Cancer Care Institute A Fox Chase Cancer Center Partner ONCOLOGY PROGRAM LEADERSHIP AND STAFF

James Wurzer, MD, PhD Medical Director, Oncology Program Medical Director, Radiation Oncology Adjunct AssociateMember, Radiation Oncology, Fox Chase Cancer Center

Cheryl Eget, CTR Oncology Data Services Supervisor

JohnD. Lorenzetti, MD, FACS Medical Director, Breast Health Program

Desiree Jangha, PhD, DABR Director, Medical Physics, RadiationTherapy Services

Neha Chawla, MD InterimMedical Director, Medical Oncologist

MarciaMcCulley, MBA Oncology ProgramManager Community Outreach Coordinator

MariaVictoria Roque, RN, BSN, OCN Clinical Manager, Medical Oncology

FrankCarpenter Assistant Vice President, Oncology Services

Lacey Peterman Director, Oncology Operations

KathrynThomas, RN, BSN, OCN, CCRP Supervisor, Oncology Clinical Research

AtlantiCare Cancer Care Institute: Annual Report 2018 3

A COMPREHENSIVE APPROACH TO QUALITY CARE The AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner, provides comprehensive screening, diagnosis, treatment and survivorship planning for the most common types of cancer we see in our community — including breast, lung, prostate, colorectal and women’s reproductive cancers. As a trusted partner in the fight against cancer, we continue to sharpen our focus on treating this disease with a multidisciplinary team approach. In 2018, we continued to grow and enhance our survivorship programming to support patients in the months and years after their treatment ends. Cancer survivors have special needs for follow-up (surveillance), testing and lifestyle considerations. Our survivorship program is designed to meet those needs through individualized health monitoring and wellness care. Through this programming, launched in partnership with Carevive Systems, patients receive a personalized plan of follow-up care. Our approach brings together specialists from each patient care discipline to collaboratively develop site- specific treatment plans for every patient using current evidence-based medical guidelines. This approach also incorporates the respective expertise of our oncology nurse navigators, clinical nutritionists, social workers, palliative care, behavioral health, pain management specialists and other disciplines to address the various needs of patients with cancer. A dedicated financial counselor assists patients and families with access to financial resources. The financial counselor is a direct point of contact for patients’ questions related to out-of- pocket costs and navigation of available financial resources. In 2016, we enhanced our oncology services with the addition of a new specialty program dedicated to the treatment of complex gastrointestinal (GI) malignancies. In addition to colon and rectal cancers, this program provides all-encompassing, expert care for tumors diagnosed in the gallbladder, pancreas, esophagus, liver, appendix and other areas of the GI tract. After expanding our oncology nurse navigator program in 2017 to provide dedicated support to patients diagnosed with GI, lung cancer, prostate cancers and others, we added an oncology breast nurse navigator in 2018 to provide comfort and security as these patients navigate their journey. Our navigator programs allow us to better serve patients by providing one point of contact throughout the treatment process, which makes it easier for patients to follow through on the recommendations of their treatment team. The oncology team at AtlantiCare is proud to have earned national accreditation from the American College of Surgeons Commission on Cancer and the American College of Radiology. We believe in providing the quality, cutting-edge cancer care that our patients need and deserve. Sincerely,

Frank Carpenter Assistant Vice President, Oncology Services

James C. Wurzer, MD, PhD Medical Director, Oncology Program; Medical Director, Radiation Oncology,

AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner

AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner Adjunct Associate Member, Department of Radiation Oncology, Fox Chase Cancer Center

4 AtlantiCare Cancer Care Institute: Annual Report 2018

OPERATIONS LEADERSHIP CORNER

More people are surviving cancer than ever before, and AtlantiCare Cancer Care Institute is proud to do our part in the southeastern New Jersey communities we serve.

As a Fox Chase Cancer Center Partner, we offer the full spectrum of cancer care – from prevention and early detection, to advanced treatment options, clinical trials, genetic counseling and a comprehensive range of support services to see you through your journey. Our dedicated cancer care team is led by some of the region’s leading oncologists, known as much for their compassionate care as their skill in fighting cancer. These specialists work in close partnership with surgeons, oncology-certified nurses, pharmacists, social workers, navigators and other experts to create a fully personalized treatment plan. We’ve invested millions of dollars to bring new technologies and cutting-edge clinical trials to our community. We continue to expand our team and add more specialists as we take a holistic approach to treating cancer. AtlantiCare remains committed to bringing the best cancer treatments and doctors to southeastern New Jersey. We believe you should be close to home and your loved ones when you are being treated for cancer. With AtlantiCare as your partner, you don’t have to drive to another state or outside the region to find the high-quality, specialty cancer care you need.

Sincerely,

Lacey Peterman Director, Oncology Operations

Maria Victoria Roque, BSN, RN, OCN Clinical Manager, Medical Oncology

Marcia McCulley, MBA Oncology ProgramManager Community Outreach Coordinator

AtlantiCare Cancer Care Institute: Annual Report 2018 5

2018 HIGHLIGHTS AND ACHIEVEMENTS • The Oncology Program achieved: - American College of Surgeons Commission on Cancer (ACOS) re-accreditation, including four commendations. - Association of Community Cancer Centers (ACCC) programmembership. - CEO (Chief Executive Officer) Cancer Gold Standard workplace wellness accreditation. - American College of Radiology accreditation for Egg Harbor Township and Cape May Court House campuses for Radiation Therapy, Gold Standard for Radiation Therapy accreditation. • AtlantiCare continued its participation in the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Oncology Care Model (OCM), which focuses on care coordination, appropriateness and access for Medicare beneficiaries receiving chemotherapy. • AtlantiCare began offering genetic counseling services onsite at the Cancer Care Institute. • All eligible RNs have earned or maintained certification as an Oncology Certified Nurse (OCN®). • AtlantiCare expanded its nurse navigation services to further enhance transition of care. • Our oncology nursing team participated in the Healing Arts for Nurses week. • The AtlantiCare Cancer Care Institute provides inpatient coverage and consultation to current patients when in the hospital, including the hiring of an additional nurse practitioner to support that service. • AtlantiCare provides a weekly onsite Palliative Care Clinic, run with a palliative care specialist physician and nurse practitioner, as a service for our patients to assist with symptommanagement.

6 AtlantiCare Cancer Care Institute: Annual Report 2018

ATLANTICARE IS BRINGING THE MOST ADVANCED RADIATION TREATMENT TECHNOLOGY TO OUR PATIENTS

To ensure our patients have access to the latest treatment technologies, in 2018 the AtlantiCare Cancer Care Institute installed two of the latest- generation linear accelerators in our Radiation Oncology department. AtlantiCare radiation oncologists use these devices to deliver precisely focused beams of X-ray energy to shrink or eliminate solid-tumor cancers in major organs and other areas within the body. In particular, external-beam radiation therapy is widely used for prostate, breast and lung cancers, three of the most common malignancies in our community.

The new linear accelerators are among few around the world. The Varian TrueBeam is a sharpshooter and is effective against tumors that were considered untreatable in the past. This state-of-the-art technology reduces treatment time, while its effectiveness reduces the number of required sessions. Patients don’t need to travel to a major city for this treatment – it is available here in southeastern New Jersey. This technology is better for the patient and for families and loved ones. The accelerator times the dose and physically moves the patient in three dimensions to compensate for position, breathing and the tiniest movement of organs and muscles. Even if the patient coughs, sneezes or shifts position, it adjusts on the fly, keeping the radiation precisely where it belongs. The daily priority of Dr. James Wurzer, Medical Director, Radiation Oncology at the AtlantiCare Cancer Care Institute, is improving the quality of patients’ lives. “It’s truly an honor to care for cancer patients and see their success. There is no better privilege for a physician,” Dr. Wurzer says. “We continue to bring in the best equipment and staff to help our community – we are treating our friends and family. We are investing in our future.”

AtlantiCare Cancer Care Institute: Annual Report 2018 7

8TH ANNUAL RELAY FOR LIFE DR. VASTHI WILSONWAS PRESENTEDWITH THE HONORARY HEALTHCARE CHAMPION AWARD. June 8, 2018 – Mainland Regional High School, Linwood Relay for Life is not just an event, but a life-changing experience. This year, Relay for Life of Linwood raised over $50,000, with 500 participants and 50 survivors, all of which was made possible by the support of AtlantiCare.

RIBBONS OF HOPE June 1, 2018 – Assumption Regional Catholic School, Galloway The “Ribbons of Hope” field day event has raised more than $10,000 in two years’ time to benefit the AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner. The event raises funds and awareness on the prevention, detection, and treatment of cancer, while engaging students to make a difference in their community.

ATLANTICARE CANCER CARE INSTITUTE CELEBRATES AND HONORS SURVIVORS June 5, 2018 – Egg Harbor Township June 6, 2018 – Cape May Court House During Cancer Survivors Week, events were held on both campuses to celebrate patients and their families. As part of the ShopRite LPGA Classic, LPGA pros were on hand to lend friendly tips on putting.

HEROES OF HAIR November 2018

AtlantiCare Heroes of Hair, a No Shave November fundraising initiative raised over $25,000 to support cancer patients in the community. Hundreds of supporters skipped a shave or halted a haircut in the name of fundraising. The brave

participants and those who supported themwere applauded at a celebration event at month’s end.

8 AtlantiCare Cancer Care Institute: Annual Report 2018

GENETIC COUNSELING CORNER In 2018, AtlantiCare Cancer Care Institute introduced its genetic counseling program in an effort to enhance the continuum of care for those at the highest risk of developing cancer. Licensed Genetic Counselor Laina Lusk, MMSc, LGC, works with physicians and nurses to identify patients who may benefit from genetic testing and coordinates their care. Most cancers occur by chance. However, if a person is born with certain changes in their genes, his or her risk for developing cancer can increase dramatically. Only five to 10 percent of cancers are caused by genetic changes, called mutations, but finding a genetic mutation in a patient can have huge implications for the patient and his or her family. For example, the risk of developing breast cancer is 12.5 percent for the average woman, but as high as 80 percent for women with a mutation in the BRCA1 gene. In addition, women with BRCA1 mutations are at increased risk for ovarian and other cancers, while men with BRCA1 mutations are at increased risk for breast, prostate, and other cancers as well.

As AtlantiCare’s genetic counselor, Lusk’s goal is to make genetics personal and easy to understand. When patients come for a genetic counseling session, she reviews their personal history of cancer, draws out their family tree, and provides relevant information about genetic testing and inherited risk. She works with patients to choose the right genetic test for them and, if they wish, they can then provide a saliva sample for testing right in her ofce. When results come back, Lusk meets with patients to explain what the results mean in practical terms, and works with their providers to ensure they receive the care they need. Genetic counselors help patients and their family members navigate the sometimes overwhelming process of genetic testing and diagnosis. They meet with patients diagnosed with cancer at a young age, rare cancers, or family histories that suggest an inherited risk, and help determine whether genetic testing is right for them. They answer questions and break down complicated genetic information into plain language. Once someone is found to carry a genetic mutation, genetic counselors walk the patient through the next steps of management. This can mean screenings, surgeries, medications and other monitoring to reduce the risk of cancer or to catch it as early as possible. It also means identifying family members who are at risk of carrying the same genetic change, and making sure they receive the testing they need. Facing this kind of risk can be frightening, but genetic counselors help support patients and empower them to take control of their health and disease management.

Laina Lusk, MMSc, LGC Licensed Genetic Counselor

AtlantiCare Cancer Care Institute: Annual Report 2018 9

ONCOLOGY DATA SERVICES AtlantiCare Cancer Care Institute is accredited by the American College of Surgeons Commission on Cancer (CoC). The CoC is a consortium of professional organizations dedicated to improving the survival and quality of life for cancer patients by establishing evidenced-based national standards and by monitoring the quality of cancer care at accredited programs. The National Cancer Database (NCDB) is a nationwide cancer database of patients treated at CoC-accredited programs. The Cancer Registry team at the AtlantiCare Cancer Care Institute is responsible for capturing a complete history, diagnosis, first course of treatment and health status for every cancer patient at AtlantiCare in a timely manner. Each patient is followed for the course of his or her lifetime after diagnosis. The Cancer Registry team also organizes and participates in multidisciplinary oncology conferences and supports the AtlantiCare Cancer Committee in addition to the cancer program.

AtlantiCare uses registry data for research and to evaluate patient outcomes and the allocation of resources within the cancer program. In addition, we use the data in our community health needs assessments and in our community education and outreach activities to address identified needs in the area. Registry data is submitted to the NCDB and to the New Jersey State Department of Health Cancer Registry for reporting of National Quality Measures. The AtlantiCare Cancer Committee utilizes the NCDB’s accountability reporting tool to monitor our quality performance and outcomes, and to serve as a benchmark to focus quality improvement opportunities that support high-quality care.

Cheryl Eget, CTR Supervisor, Oncology Data Services

10 AtlantiCare Cancer Care Institute: Annual Report 2018

CANCER REGISTRY DATA – 2017 ANALYTIC CASES *

PRIMARY SITE

TOTAL

MALE

FEMALE

ORAL CAVITY & PHARYNX

28 12

18 10

10

Tongue

2 2 0 1 3 2 0 3 0 0 5 3 6 1 2 2 1 2 9 2 7 4 3 3 0 2 0 0 1 2 2 6 6 0 1

Salivary Glands Gum & Other Mouth Nasopharynx

3 2 2 5 3 1 5 1 9 3 2 5 3 6

1 2 1 2 1 1 5 1 4 0 5 1 3 1 5 9 3 9 1 8 1 8 2 1 1

Tonsil

Oropharynx Hypopharynx DIGESTIVE SYSTEM

156

84 11

72

Esophagus Stomach Small Intestine

14

Colon (excluding Rectum)

65

31

34

Cecum Appendix

Ascending Colon Hepatic Flexure Transverse Colon Splenic Flexure Descending Colon Sigmoid Colon Large Intestine, NOS Rectum & Rectosigmoid Rectosigmoid Junction

11

21

12

5

18

3

Rectum

15

Anus, Anal Canal & Anorectum Liver & Intrahepatic Bile Duct

5

13 11

10

Liver

Intrahepatic Bile Duct

2 3 1

Gallbladder Other Biliary Pancreas

30

14

16

Peritoneum, Omentum & Mesentery

1

0

RESPIRATORY SYSTEM

110

59

51

Nose, Nasal Cavity & Middle Ear

1 6 5 5

1 5 3 3

Larynx

Lung & Bronchus

103

53

50

SOFT TISSUE

Soft Tissue (including Heart) SKIN EXCLUDING BASAL & SQUAMOUS

21 19

15 13

Melanoma – Skin Other Non-Epithelial Skin

2

2 1 1

BREAST

203 203

202 202

Breast

AtlantiCare Cancer Care Institute: Annual Report 2018 11

CANCER REGISTRY DATA – 2017 ANALYTIC CASES * (continued)

PRIMARY SITE

TOTAL

MALE

FEMALE

FEMALE GENITAL SYSTEM

38 21 20 4

0 0 0 0 0 0 0

38 21 20 4

Cervix Uteri

Corpus & Uterus, NOS

Corpus Uteri Uterus, NOS

1 7 6

1 7 6 0 0 0 0 6 4 2 8 5 9 3 4 4 4 1 3 0 0 6 6 0

Ovary Vulva

MALE GENITAL SYSTEM

75 73

75 73

Prostate Testis

1 1

1 1

Other Male Genital Organs

URINARY SYSTEM

26 20 29 14 22 18 34 6 4 32 24 2

20 16 16 4

Urinary Bladder Kidney & Renal Pelvis

BRAIN & OTHER NERVOUS SYSTEM

13

Brain

6

Cranial Nerves, Other Nervous System 15

10

ENDOCRINE SYSTEM

6 3 3

16 15 12 1

Thyroid

Other Endocrine including Thymus

LYMPHOMA

22 20 15 2

Hodgkin Lymphoma Non-Hodgkin Lymphoma

12

NHL - Nodal NHL - Extranodal

8 8 8 7 2 5 1 1

5 4 4 3 1 2 1 1

MYELOMA

Myeloma

LEUKEMIA

Lymphocytic Leukemia Myeloid & Monocytic Leukemia

MESOTHELIOMA Mesothelioma MISCELLANEOUS Miscellaneous

20 20

14 14

TOTAL

783

341

442

*Cases for which AtlantiCare provided the initial diagnosis of cancer and/or for which AtlantiCare contributed to the patient’s first course of treatment.

12 AtlantiCare Cancer Care Institute: Annual Report 2018

OUTCOMES

QUALITY PERFORMANCE MEASURES Below are the American College of Surgeons Commission on Cancer (CoC) quality performance benchmark standards comparing AtlantiCare with other CoC organizations in New Jersey and the United States.

Top Six Primary Sites 2007 - 2017 Analytic Cases

250

CoC standard for surgery is not the first course of treatment for node positive lung cancer

200

100%

150

100%

89% 93%

100

90%

Number of Patients

80%

50

70%

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

2017

60%

50%

Breast

Prostate Gland

Lung

0

Colorectal

Corpus & Uterus

Bladder

All CoC in US

CoC Benchmark 85% AtlantiCare All CoC in NJ

Surgery is not the first course of treatment for cN2, M0 lung cases.

CoC standard for regional lymph nodes in surgically resected colon cancer

Analytic vs. Non-Analytic Cases 2015 - 2017

100%

93% 93% 93%

90%

1200

80%

1000

70%

800

60%

600

50%

0

400

All CoC in US

CoC Benchmark 85% AtlantiCare All CoC in NJ

200

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.

0

2015

2016

2017

CoC standard for breast-conserving surgery and radiation therapy in breast cancer

Analytic

Non-Analytic

100%

95%

2015: Analytic: 943 Non-Analytic: 274

91% 93%

90%

2016: Analytic: 811 Non-Analytic: 222

80%

2017: Analytic: 783 Non-Analytic: 233

70%

60%

50%

0

All CoC in US

CoC Benchmark 90% AtlantiCare All CoC in NJ

Radiation is administered within 1 year (365 days) of diagnosis for women under the age of 70 receiving breast conservation surgery for breast cancer.

AtlantiCare Cancer Care Institute: Annual Report 2018 13

OUTCOMES (continued)

MONITORING COMPLIANCEWITH EVIDENCE-BASED GUIDELINES FOR NON-SMALL CELL LUNG CARCINOMA

Reporting year: 2018 Accession year reviewed: 2017 Number of cases reviewed: 8 Guideline: NCCN Guidelines® for Non-Small Cell Lung Cancer Version 1.2019 Reviewer: Vasthi ChristensenWilson, MD, MSc Date presented: November 29, 2018 Vital to the success of the AtlantiCare Cancer Care Institute is continuous evaluation of performance in order to improve patient outcomes, emphasizing a professional commitment to safety and quality. This year, the Cancer Committee designated stage III non-small cell lung carcinoma for an in-depth analysis to assess and verify that cancer programpatients are evaluated and treated according to evidence-based national treatment guidelines. Lung cancer is the most common cause of cancer death in the United States. Lung cancers are classified as either small

Vasthi Christensen Wilson, MD, MSc

cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). This distinction is required for proper staging, treatment, and prognosis. This formal reviewwith analysis results represents a full evaluation of patients diagnosed with NSCLC between February and October 2017. Results were presented to the Cancer Committee and documented in Cancer Committee minutes. Initial evaluation of patients presenting to the AtlantiCare Cancer Care Institute with the diagnosis of NSCLC was considered appropriate when the following criteria were documented/met: history/physical examination, pulmonary function test (PFT), bronchoscopy, mediastinal lymph node evaluation, FDG PET/CT imaging, brain MRI with contrast, and standard blood work. Patients were staged appropriately utilizing American Joint Committee on Cancer (AJCC) stagingmethods. Review of the workup of these patients was concordant with evidence-based national guidelines in all cases. Treatment for this patient cohort included standard systemic chemotherapy consisting of either weekly carboplatin with paclitaxel or carboplatin with pemetrexed delivered every 21 days during the course of the radiation followed by durvalumab where indicated. Thoracic external beam radiation therapy (EBRT) was prescribed to a dose of 61.2Gy, divided into planned revision phases to account for tumor reduction during treatment with respect to normal organ tolerances (such as heart, esophagus, and spinal cord). Treatment plan criteria were consideredmet if the recommended surgery, systemic therapy, and radiotherapy was documented as completed, or as recommended but not completed as planned for reasons stated in the medical record (i.e. contraindication, comorbidities, treatment toxicity, patient death, refusal or non-compliance). Review of treatment plans for these patients was concordant with evidence-based national guidelines in all cases. In summary, this analysis confirms compliance with national guidelines. Collaborative coordination of care betweenmedical oncology, thoracic surgery, pathology, diagnostic radiology, and radiation oncology was evident during case review at monthly multidisciplinary Thoracic Oncology Conference. High quality clinical services – including state-of the-art pretreatment evaluation, staging, individualized treatment, and clinical follow up were verified as provided for AtlantiCare NSCLC patients.

14 AtlantiCare Cancer Care Institute: Annual Report 2018

OUTCOMES: QUALITY IMPROVEMENT

IMPROVINGWAIT TIMES IN THE INFUSION SUITE IN MEDICAL ONCOLOGY

TEAMMEMBERS: Dr. Neha Chawla, InterimMedical Director, Medical Oncology Maria Victoria Roque, BSN, RN, OCN, Clinical Manager, Medical Oncology

Josefina Ellis, BSN, RN, OCN; Kimberly Vaccaro, BSN, RN-BC; Frances Goldberg, RN, OCN; Tara Rodgers, RN, OCN; Victoria Nicolicchia, RN, OCN; Rhoda Cabrera, BSN, RN, OCN; Danielle Foell, BSN, RN; Jean Guanchez, RN, OCN; Jonathan Morgan, RN; Jennifer Pepper, RN; Michelle Moscola, RN Oncology care has evolved, shifting from the inpatient to ambulatory setting. It is important tomeet the challenges of stafng, scheduling and patient service to create a positive patient experience. Quality care centered on wait times is one of the determinants of patient satisfaction. (Matthews, et.al., 2015). For this study, wait time is defined as the point when a patient registers through the time they are led to an infusion suite. This year, the Cancer Committee identified wait times as an area for improvement in Medical Oncology. A review of 2017 wait times at the Egg Harbor Township location was conducted at the

Maria Victoria Roque, BSN, RN, OCN

beginning of 2018. Meetings were held with identified stakeholders, including front desk staff, laboratory, pharmacy and infusion nurses to outline the patient flow process. Through this review, several opportunities for refining the patient experience were identified. During the first six months of 2018, several process improvement initiatives were introduced, all designed to positively impact the patient experience. These included the use of check-in sheets at the front desk; infusion nurses completing chart prep a few days prior to a patient’s scheduled visit; and an increase in stafng to include the addition of twomedical oncologists and three practice nurses to the cancer center roster. The increased collaboration and implementation of new processes have contributed to an improvement in patient wait times. In 2017, the highest monthly wait time average was 44.5 minutes, and the average wait time for the year was 31.04 minutes. During the first six months of 2018, the monthly wait time average was 22.76 minutes. The Medical Oncology team continues to refine its patient flow process, including the introduction of a designated triage nurse, with a teamgoal tomaintain an average wait time of less than 20 minutes by the end of 2018.

AverageWait Times, EHT 2017-2018

50 45 50 35 30 25 20 15 10

2017

2018

5 0

July

May

June

April

March

August

October

January

February

December

November

September

Reference: Mathews, M., Ryan, D., Bulman, D. (2015). Patient-expressed perceptions of wait-time causes and wait-related satisfaction. Current Oncology, 22(2): 105-112.

AtlantiCare Cancer Care Institute: Annual Report 2018 15

PROVIDING EXCEPTIONAL CANCER CARE CLOSE TO HOME When the diagnosis is cancer, patients don’t have to drive far to find exceptional quality care or to get a second opinion. From evaluation and diagnosis to treatment, psychosocial support, wellness services and recovery — everything patients and their families need is close by at the AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner. AtlantiCare Cancer Care Institute is accredited by both the American College of Surgeons Commission on Cancer for our overall program and by the American College of Radiology for radiation therapy.

CLINICAL SERVICES • Medical oncology and infusion services • Radiation oncology • Surgical oncology • Clinical trials • Diagnostic imaging • Genetics counseling

SUPPORT SERVICES • Oncology social worker

• Transportation to medical appointments • Behavioral health services • Palliative care program • Pastoral care program • Respecting Choices program for Advance Care Planning • Financial counseling • Community education and cancer screening

• Oncology nurse navigators • Mammography scheduling • Nutrition counseling with a registered dietitian • Gilda’s Club at AtlantiCare: integrated psychosocial support programs on-site, including support groups, education and healthy lifestyle workshops that promote health and well-being

ADVANCING CANCER CARE THROUGH CLINICAL RESEARCH Clinical trials (research studies) help medical researchers understand more about cancer and its treatment. Everything we know today about how to treat cancer was learned through a clinical trial. Through membership in the Geisinger National Community Oncology Research Program (NCORP), and as a Fox Chase Cancer Center Partner, AtlantiCare Cancer Care Institute is proud to o er patients with cancer in our community the chance to take part in clinical trials that test new ways to diagnose and/or treat cancer and new ways to improve the lives of those with cancer. Joining a clinical trial is a personal decision. People take part in clinical trials for many reasons, including gaining access to new treatments that are not yet widely available and wanting to make a di erence for others who will be diagnosed with cancer in the future. Patients may choose to take part or not, and they are free to leave at any time. The Supervisor of AtlantiCare Oncology Clinical Research helps patients understand what clinical trials may be available for them and their type of cancer. The research nurses explain everything patients need to know to make an informed decision about whether or not to take part. For more information about clinical trials at the AtlantiCare Cancer Care Institute, call 609-677-7735.

Kathryn Thomas, RN, BSN, OCN, CCRP Supervisor, Oncology Clinical Research

16 AtlantiCare Cancer Care Institute: Annual Report 2018

NURSE NAVIGATOR’S CORNER

Ensuring a seamless care experience for patients and their families. When you’re fighting cancer, it’s reassuring to have an advocate in your corner to help with appointment scheduling, specialist referrals, treatment side e ects and other aspects of your care. At the AtlantiCare Cancer Care Institute, a Fox Chase Cancer Center Partner, patients are personally guided through the continuum of care by oncology nurse navigators such as Evelyn Darretta, BSN, RN, OCN, and Tracie Rodriguez, RN, OCN. Evelyn is dedicated full time to assisting women and men diagnosed with breast cancer, while Tracie advocates for patients with complex GI, lung and prostate cancers, as well as others that need coordination of care. Both are integral members of the multidisciplinary patient care teamworking one on one with patients and their loved ones to coordinate all the necessary details before, during and after treatment.

“My goal is to always treat my patients with the care I would want my family or myself to receive. When dealing with a cancer diagnosis, patients and their families endure difficult emotional and physical struggles. Comfort and security can be felt when knowing how to prepare and plan for your care. I want to be there to help individuals through their journey.” Evelyn brings more than 20 years of medical oncology nursing experience to her role as breast nurse navigator on the AtlantiCare team. In this role, Evelyn serves as a patient advocate and care coordinator for women and men diagnosed with breast cancer and their personal support systems. She is highly skilled in administering chemotherapy and biotherapy in an outpatient setting, and in providing supportive care to patients throughout their therapy. “I have dedicatedmyself to providing individualized care to patients and their family members through the treatment, journey and beyond. I want those inmy care to feel part of a family withme and with our team to help decrease their fear and heal with less worry during this stressful time.” Tracie joined AtlantiCare Regional Medical Center (ARMC) in 2002 and has provided patient care in various clinical areas, including the Oncology department at ARMC Mainland Division, the outpatient and inpatient operating rooms and recovery room at ARMC Surgery Center, and the Radiation Oncology department of the AtlantiCare Cancer Care Institute. Most recently, she was the lead registered nurse working directly with James Wurzer, MD, PhD, medical director of Radiation Oncology.

Evelyn Darretta, BSN, RN, OCN

Tracie Rodriguez, RN, OCN

In addition to providing individualized patient education, our navigators assist by enhancing access to services and helping patients overcome any barriers to care, such as transportation, insurance issues or language translation. Both Evelyn and Tracie also promote the emotional and physical well-being of patients in addition to focusing on their medical needs.

AtlantiCare Cancer Care Institute: Annual Report 2018 17

TAKING CARE AND GIVING BACK In addition to specialized medical services for the diagnosis and treatment of cancer, community education and outreach are important elements in the service continuum at AtlantiCare Cancer Care Institute. AtlantiCare’s community outreach in 2018 included support groups, cancer prevention and screening programs, and support of events and nonprofit organizations that benefit community members in the fight against cancer.

Community Education and Screening • Health fairs, workshops and educational lectures on various cancer-related topics • Men’s Health prostate screening • Screening mammograms • Skin cancer health assessments and prevention education events Event Sponsorship and Participation • American Cancer Society events • American Heart Association • Atlantic City Rescue Mission breast health talk • Every Breath Counts, Lung Cancer Walk/Run

• “Survivors Are Our Superstars” community event • Somers Point Beach Concert Series • Tobacco Cessation classes

• Ladies Invitational Blue Fish Tournament • Ribbons of Hope • Ruth Newman Shapiro Cancer and Heart Fund events • Shirley Mae Run and Michael J. Walk • Susan G. Komen events • Tara Miller Melanoma Foundation Gala

• Gilda’s Club South Jersey events • Hammonton Cancer Foundation • Heroes of Hair, No Shave November • JCC Health Fair

18 AtlantiCare Cancer Care Institute: Annual Report 2018

ATLANTICARE CANCER COMMITTEE MEMBERS The AtlantiCare Cancer Committee is composed of primary and specialty care physicians, as well as hospital sta and providers with a direct role in caring for our oncology patients. The multidisciplinary committee meets regularly to review and evaluate the quality and direction of the overall oncology program and makes recommendations for improvement.

Required Physician Members Mitchell Brezel, MD Diagnostic Radiologist Neha Chawla, MD InterimMedical Director, Medical Oncologist John Lorenzetti, MD, FACS Medical Director of Breast Program Breast Surgeon WilliamTodd, MD Pathologist JamesWurzer, MD, PhD Medical Director, Oncology Program Medical Director, Radiation Oncology Cancer Committee Chairman Cancer Liaison Physician Adjunct Associate Member, Radiation Oncology, Fox Chase Cancer Center

Laina Lusk, MMSc, LGC Genetic Counselor

Desiree Jangha, PhD, DABR Director, Medical Physics, Radiation Therapy Services Mary Law, MSN, RN Assistant Vice President of Quality/Accreditation David Levi, MD Diagnostic Radiologist Maria Marine Ortiz-San Oncology Data Services Yanny Mejia, BSc, MBA Oncology Analyst Christine Miller, RN Oncology Clinical Research Associate

Marcia McCulley, MBA Oncology ProgramManager Community Outreach Coordinator Nancy McGrath, RHIT, CTR Cancer Conference Coordinator Maria Victoria Roque, BSN, RN, OCN Quality Improvement Coordinator Clinical Manager, Medica l Oncology Janine Sooy, RN Quality Management Representative Kathryn A. Thomas, RN, BSN, OCN, CCRP Supervisor, Oncology Clinical Research BSN, RN, OCN Nurse Navigator Vicki DiStephano, RN, OCN Radiation Nurse Bonnie Duboff Registered Dietitian Kelly Filchner, MSN, RN, OCN, CCRC Fox Chase Cancer Center Liaison Audrey Heist, MPH, RD Director of Health Engagement Juliann Henry, MDiv Pastoral Care Representative Additional Members Bruno Dantas, MD Pathologist Evelyn Darretta,

Rajesh Nahar, MD Medical Oncologist Natalie Obradobich American Cancer Society Representative Lacey Peterman

Required Non-Physician Members Frank Carpenter Assistant Vice President, Oncology Services Bhargavi Degapudi, MD Palliative Care Elizabeth Eble, DNP, APN Palliative Care Cheryl Eget, CTR

Director, Oncology Operations Tracie Rodriguez, RN, OCN Nurse Navigator Kelly Sanders, BSN, RN Hospice Cathy Sutman, MSW Psychosocial Services Coordinator Social Worker Vasthi Wilson, MD, MSc

Cancer Registry Quality Coordinator Supervisor, Oncology Data Services Samantha Hill, MSW Psychosocial Services Coordinator Social Worker

Radiation Oncologist Ruifeng Zhou, MD Medical Oncologist

AtlantiCare Cancer Care Institute: Annual Report 2018 19

AtlantiCare Health Park 2500 English Creek Avenue, Building 400 Egg Harbor Township, NJ 08234

106 Court House South Dennis Road, Building 200 Cape May Court House, NJ 08210 1-888-569-1000 www.atlanticare.org/cancer